Imatinib-Resistant CML Cells Have Low ENT Activity But Maintain Sensitivity to Gemcitabine
Author:
Publisher
Informa UK Limited
Subject
Genetics,Molecular Medicine,Biochemistry,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/15257770802145892
Reference18 articles.
1. Treatment of chronic myelogenous leukemia: current status and investigational options [see comments]
2. Chronic Myelogenous Leukemia: Biology and Therapy
3. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
4. Imatinib mesylate (STI571) therapy for Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase
5. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population;Cancer Chemotherapy and Pharmacology;2024-06-18
2. Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors;Journal of Biological Chemistry;2016-09
3. Comparison of Human Nucleoside Transporter Interactions with BCR-ABL Kinase Inhibitors;Annals of Oncology;2015-03
4. Physicochemical properties of novel protein kinase inhibitors in relation to their substrate specificity for drug transporters;Expert Opinion on Drug Metabolism & Toxicology;2015-01-29
5. Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?;Molecular Cancer Therapeutics;2014-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3